|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
Innophos Holdings 8-K 2011 Documents found in this filing:
UNITED STATES
FORM 8-K
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported: November 8, 2011)
Innophos Holdings, Inc.
259 Prospect
Plains Road
(609) 495-2495
Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Items.
As previously announced, on November 9, 2011, the Registrant’s senior management is scheduled to host an “investor day” in New York City to present and discuss a broad range of aspects concerning the Registrant’s business. A live or replay webcast of the event is accessible at the Registrant’s website www.innophos.com under “Investor Relations—Upcoming Events.” A copy of the materials to be presented is filed as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
The following exhibits are filed with this report:
According to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Dated: November 8, 2011.
|
| |||||||